Brooks Laboratories Limited (NSE:BROOKS)
India · Delayed Price · Currency is INR 66.38
+2.53 (3.96%)
Sep 11, 2026, 3:29 PM IST
Brooks Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,935 | 1,093 | 3,167 | 2,457 | 1,540 | 1,801 | |
Market Cap Growth | -56.59% | -65.49% | 28.93% | 59.50% | -14.47% | 18.92% |
Enterprise Value | 1,953 | 1,161 | 3,249 | 2,494 | 2,350 | 2,300 |
Last Close Price | 65.69 | 37.11 | 106.36 | 93.60 | 61.76 | 72.21 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 14.62 | 4.45 | - | - | - | - |
PS Ratio | 2.33 | 1.27 | 3.84 | 3.09 | 2.44 | 1.98 |
PB Ratio | 1.58 | 0.89 | 3.23 | 3.75 | 2.08 | 1.34 |
P/TBV Ratio | 1.58 | 0.89 | 3.23 | 3.75 | 2.09 | 2.07 |
P/FCF Ratio | 33.43 | 18.89 | 185.94 | - | - | - |
P/OCF Ratio | 20.82 | 11.76 | 120.60 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.35 | 1.35 | 3.94 | 3.14 | 3.72 | 2.52 |
EV/EBITDA Ratio | 13.06 | 15.98 | 65.70 | 68.99 | - | - |
EV/EBIT Ratio | 14.60 | 19.27 | 88.28 | 116.99 | - | - |
EV/FCF Ratio | 33.75 | 20.06 | 190.74 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.07 | 0.07 | 0.08 | 0.09 | 0.09 | 0.19 |
Debt / EBITDA Ratio | 1.35 | 1.12 | 1.44 | 1.45 | - | - |
Debt / FCF Ratio | - | 1.47 | 4.45 | - | - | - |
Net Debt / Equity Ratio | 0.02 | 0.02 | 0.07 | 0.08 | 0.09 | 0.17 |
Net Debt / EBITDA Ratio | 0.31 | 0.25 | 1.47 | 1.53 | -0.24 | -1.58 |
Net Debt / FCF Ratio | - | 0.32 | 4.27 | -0.54 | -0.43 | -0.35 |
Asset Turnover | - | 0.63 | 0.77 | 0.80 | 0.41 | 0.51 |
Inventory Turnover | - | 5.14 | 5.81 | 5.45 | 2.70 | 2.50 |
Quick Ratio | - | 1.16 | 1.03 | 0.79 | 0.40 | 0.44 |
Current Ratio | - | 1.72 | 1.48 | 1.35 | 0.84 | 1.25 |
Return on Equity (ROE) | - | 22.27% | -12.18% | -28.08% | -29.81% | -18.09% |
Return on Assets (ROA) | - | 2.77% | 2.15% | 1.33% | -13.67% | -7.46% |
Return on Invested Capital (ROIC) | 3.81% | 5.24% | 4.17% | 2.81% | -28.14% | -15.46% |
Return on Capital Employed (ROCE) | - | 4.80% | 3.60% | 3.20% | -43.60% | -14.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 6.83% | 22.49% | -3.15% | -7.98% | -13.56% | -6.27% |
FCF Yield | 2.99% | 5.29% | 0.54% | -4.17% | -9.71% | -36.12% |
Buyback Yield / Dilution | -5.98% | -9.95% | -4.59% | -3.70% | - | - |